Monday, May 23, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Gene replacement therapy could help mend a broken heart, study suggests

by Medical Finance
in News
Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts
9
SHARES
102
VIEWS
Share on FacebookShare on Twitter

How can you mend a broken heart? According to researchers from Japan, in some cases gene replacement therapy just might do the trick.

In a study published in January in Stem Cell Reports, researchers from Osaka University report that heart cells from a patient with an inherited heart disease called arrhythmogenic cardiomyopathy do not contract correctly when grown in the laboratory, and that replacing the mutated gene responsible for this effect fixes this defect.

Arrhythmogenic cardiomyopathy occurs due to mutations in genes involved in desmosomes, which form ‘welds’ between cells that help them communicate and move in a coordinated way. One of these genes, PKP2, encodes a protein known as plakophilin-2 that is crucial to maintaining heart cell structure.

“Previous studies carried out in cardiomyocytes have shown that mutations in PKP2 play a pathological role in arrhythmogenic cardiomyopathy,” says lead author of the study Hiroyuki Inoue. “However, the cells used in those experiments were derived from healthy individuals and were not assessed for contractile function.”

To investigate how cells derived from patients behave in the laboratory, the researchers first took a blood sample from a young patient with arrhythmogenic cardiomyopathy, induced some of the blood cells to become stem cells, and then differentiated these stem cells into heart cells. They then modified this original batch of heart cells into three different cell lines with precisely adjusted PKP2 expression based on how many mutated or intact copies of the gene were present.

The cells with two mutated copies of PKP2 clearly exhibited reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency. These effects were also observed in cells with only one mutated copy of PKP2, although they were less severe.”


Shuichiro Higo, Study Senior Author, Osaka University

Replacing the mutated PKP2 with an intact copy of the gene repaired the defects in both cell contraction and desmosome assembly, which the researchers were able to observe using a time-lapse approach and fluorescently labeled desmosomes.

“These findings suggest that our cardiomyocyte cell lines recapitulate the pathology of arrhythmogenic cardiomyopathy and provide a rapid and convenient platform for developing gene-based therapies for this disease,” says Higo.

Given that PKP2 is the most common gene associated with arrhythmogenic cardiomyopathy, and that PKP2 mutations can lead to severe disease, new therapeutic approaches could help halt disease progression. The findings from this study suggest that gene replacement therapy could be a valuable way of treating patients with this condition and the cell lines created in this study are a viable model to test new therapies for arrhythmogenic cardiomyopathy on.

Source:

Journal reference:

Inoue, H., et al. (2022) Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes. Stem Cell Reports. doi.org/10.1016/j.stemcr.2021.12.016.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

First patient-derived stem cell model developed for studying oculocutaneous albinism

Scientists use entire human GI tracts to shed light on cellular functions

by Medical Finance
May 23, 2022
0

If you get nervous, you might feel it in your gut. If you eat chili, your gut might revolt, but...

Study: An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants. Image Credit: Design_Cells / Shutterstock.com

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

by Medical Finance
May 23, 2022
0

As of February 22, 2022, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 425 million worldwide and...

NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

New radio-labeled molecule may allow a non-invasive approach to monitor inflammation in real time

by Medical Finance
May 23, 2022
0

Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting...

Study opens the door to a new approach to attacking herpesviruses

Researchers discover how pre-transplant chemotherapy facilitates the replacement of microglial cells

by Medical Finance
May 23, 2022
0

More than 50,000 bone marrow-derived stem cell transplants are performed worldwide each year to treat a wide range of conditions,...

Certain flavonoids inhibit an enzyme involved in the formation of key hormone in yellow fever mosquito

Certain flavonoids inhibit an enzyme involved in the formation of key hormone in yellow fever mosquito

by Medical Finance
May 23, 2022
0

When most people think of flavonoids, natural compounds found in plants and other organisms, their nutritional benefits probably come to...

Scientists unravel how blood cells mount the first line of defense against viruses

Study reveals the structural, functional landscape of neutralizing antibodies against SARS-CoV-2 spike protein

by Medical Finance
May 23, 2022
0

The SARS-CoV-2 virus is continuously evolving and structural changes to the virus may impact the efficacy of antibody therapies and...

Next Post
First patient-derived stem cell model developed for studying oculocutaneous albinism

New training scheme for convolutional neural networks automates cell segmentation and counting

Scientists identify a new switch for controlling motor proteins

Scientists discover how immune proteins defend plants against invading microorganisms

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: The Effects of SARS-CoV-2 Infection on Female Fertility: A Review of the Literature. Image Credit: NIAID
    How does SARS-CoV-2 infection impact female fertility?
  • ImageForNews 710956 16502013677399621
    Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply